PUBLISHER: Persistence Market Research | PRODUCT CODE: 1220984
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1220984
Growing Prevalence of zoonotic diseases to increase the sales for Vet Compounding Pharmacies Market in the future
North America Vet Compounding Pharmacies Market: Scope of Report
The latest publication by Persistence Market Research on the North America vet compounding pharmacies market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for vet compounding pharmacies and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the North America vet compounding pharmacies market. Shareholders in the vet compounding pharmacies market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the North America vet compounding pharmacies market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research's study on the vet compounding pharmacies market offers information divided into four important segments - product, animal type, formulation and country. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
CNS Agents
Anti-Infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
Animal Type
Companion Animals
Dogs
Cats
Equine
Others
Livestock Animals
Formulations
Oral
Injectable
Others
Country
U.S.
Canada
Key Questions Answered in Report:
Which country will continue to remain the most profitable markets for North America vet compounding pharmacies over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed country?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the North America vet compounding pharmacies market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the North America vet compounding pharmacies market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the North America vet compounding pharmacies market are more accurate and reliable.
Table of Contents
1. Executive Summary
- 1.1. North America Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions and Exclusions
3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Product Innovation / Development Trends
4. Key Success Factors
- 4.1. Adoption Rate/Usage Analysis - Key Statistics
- 4.2. Value Chain Analysis
- 4.3. Regulatory Scenario
- 4.4. Product USP Analysis
- 4.5. PESTEL Analysis
- 4.6. Porter's Analysis
- 4.7. Key Promotional Strategies, By Key Players
5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. North America GDP Growth Outlook
- 5.1.2. North America Healthcare Outlook
- 5.1.3. Global Compounding Pharmacies Market Outlook
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Product Adoption Rate
- 5.2.2. Prevalence of Chronic Diseases
- 5.2.3. Strategic Collaborations
- 5.2.4. Rising Pet Adoption
- 5.2.5. Cost of Product
- 5.2.6. Treatment Regime
- 5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
- 6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Animal Type
- 6.1.3. By Formulations
- 6.1.4. By Country
- 6.2. 2022 Market Scenario
7. North America Vet Compounding Pharmacies Market Demand (in Value US$ Mn) Analysis 2014-2022 and Forecast, 2023-2033
- 7.1. Historical Market Value (US$ Mn) Analysis, 2014-2022
- 7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Product
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis, by Product, 2014-2022
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2023-2033
- 8.3.1. CNS Agents
- 8.3.2. Anti-Infective Agents
- 8.3.3. Hormones and Substitutes
- 8.3.4. Anti-inflammatory Agents
- 8.3.5. Others
- 8.4. Market Attractiveness Analysis, by Product
9. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Animal Type
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis, by Animal Type, 2014-2022
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Animal Type, 2023-2033
- 9.3.1. Companion Animals
- 9.3.1.1. Dogs
- 9.3.1.2. Cats
- 9.3.1.3. Equine
- 9.3.1.4. Others
- 9.3.2. Livestock Animals
- 9.3.1. Companion Animals
- 9.4. Market Attractiveness Analysis, by Animal Type
10. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Formulations
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) Analysis, By Formulations, 2014-2022
- 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Formulations, 2023-2033
- 10.3.1. Oral
- 10.3.2. Injectable
- 10.3.3. Others
- 10.4. Market Attractiveness Analysis, by Formulations
11. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Country
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Mn) Analysis, by Country, 2014-2022
- 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Country 2023-2033
- 11.3.1. U.S.
- 11.3.2. Canada
- 11.4. Market Attractiveness Analysis, by Country
12. U.S. Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
- 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
- 12.3.1. By Product
- 12.3.2. By Animal Type
- 12.3.3. By Formulations
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Product
- 12.4.2. By Animal Type
- 12.4.3. By Formulations
13. Canada Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
- 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
- 13.3.1. By Product
- 13.3.2. By Animal Type
- 13.3.3. By Formulations
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Product
- 13.4.2. By Animal Type
- 13.4.3. By Formulations
14. Market Structure Analysis
- 14.1. Market Analysis, by Tier of Companies
- 14.2. Market Share Analysis of Top Players
- 14.3. Market Concentration
- 14.4. Market Presence Analysis
15. Competition Analysis
- 15.1. Competition Dashboard
- 15.2. Competition Deep Dive
- 15.2.1. Hoye's Pharmacy
- 15.2.1.1. Overview
- 15.2.1.2. Product Portfolio
- 15.2.1.3. Sales Footprint
- 15.2.1.4. Key Financials
- 15.2.1.5. SWOT Analysis
- 15.2.1.6. Strategy Overview
- 15.2.1.6.1. Marketing Strategy
- 15.2.1.6.2. Product Strategy
- 15.2.1.6.3. Channel Strategy
- 15.2.2. Vertisis Custom Pharmacy
- 15.2.2.1. Overview
- 15.2.2.2. Product Portfolio
- 15.2.2.3. Sales Footprint
- 15.2.2.4. Key Financials
- 15.2.2.5. SWOT Analysis
- 15.2.2.6. Strategy Overview
- 15.2.2.6.1. Marketing Strategy
- 15.2.2.6.2. Product Strategy
- 15.2.2.6.3. Channel Strategy
- 15.2.3. Smith Caldwell Drug Store
- 15.2.3.1. Overview
- 15.2.3.2. Product Portfolio
- 15.2.3.3. Sales Footprint
- 15.2.3.4. Key Financials
- 15.2.3.5. SWOT Analysis
- 15.2.3.6. Strategy Overview
- 15.2.3.6.1. Marketing Strategy
- 15.2.3.6.2. Product Strategy
- 15.2.3.6.3. Channel Strategy
- 15.2.4. Sixth Avenue Medical Pharmacy
- 15.2.4.1. Overview
- 15.2.4.2. Product Portfolio
- 15.2.4.3. Sales Footprint
- 15.2.4.4. Key Financials
- 15.2.4.5. SWOT Analysis
- 15.2.4.6. Strategy Overview
- 15.2.4.6.1. Marketing Strategy
- 15.2.4.6.2. Product Strategy
- 15.2.4.6.3. Channel Strategy
- 15.2.5. Dougherty Pharmacy
- 15.2.5.1. Overview
- 15.2.5.2. Product Portfolio
- 15.2.5.3. Sales Footprint
- 15.2.5.4. Key Financials
- 15.2.5.5. SWOT Analysis
- 15.2.5.6. Strategy Overview
- 15.2.5.6.1. Marketing Strategy
- 15.2.5.6.2. Product Strategy
- 15.2.5.6.3. Channel Strategy
- 15.2.6. Triangle Compounding Pharmacy Inc.,
- 15.2.6.1. Overview
- 15.2.6.2. Product Portfolio
- 15.2.6.3. Sales Footprint
- 15.2.6.4. Key Financials
- 15.2.6.5. SWOT Analysis
- 15.2.6.6. Strategy Overview
- 15.2.6.6.1. Marketing Strategy
- 15.2.6.6.2. Product Strategy
- 15.2.6.6.3. Channel Strategy
- 15.2.7. Wedgewood Pharmacy
- 15.2.7.1. Overview
- 15.2.7.2. Product Portfolio
- 15.2.7.3. Sales Footprint
- 15.2.7.4. Key Financials
- 15.2.7.5. SWOT Analysis
- 15.2.7.6. Strategy Overview
- 15.2.7.6.1. Marketing Strategy
- 15.2.7.6.2. Product Strategy
- 15.2.7.6.3. Channel Strategy
- 15.2.8. Millers Pharmacy
- 15.2.8.1. Overview
- 15.2.8.2. Product Portfolio
- 15.2.8.3. Sales Footprint
- 15.2.8.4. Key Financials
- 15.2.8.5. SWOT Analysis
- 15.2.8.6. Strategy Overview
- 15.2.8.6.1. Marketing Strategy
- 15.2.8.6.2. Product Strategy
- 15.2.8.6.3. Channel Strategy
- 15.2.9. Chiron Compounding Pharmacy
- 15.2.9.1. Overview
- 15.2.9.2. Product Portfolio
- 15.2.9.3. Sales Footprint
- 15.2.9.4. Key Financials
- 15.2.9.5. SWOT Analysis
- 15.2.9.6. Strategy Overview
- 15.2.9.6.1. Marketing Strategy
- 15.2.9.6.2. Product Strategy
- 15.2.9.6.3. Channel Strategy
- 15.2.10. MEDS Canadian Compounding Pharmacy
- 15.2.10.1. Overview
- 15.2.10.2. Product Portfolio
- 15.2.10.3. Sales Footprint
- 15.2.10.4. Key Financials
- 15.2.10.5. SWOT Analysis
- 15.2.10.6. Strategy Overview
- 15.2.10.6.1. Marketing Strategy
- 15.2.10.6.2. Product Strategy
- 15.2.10.6.3. Channel Strategy
- 15.2.11. Aurora Compounding
- 15.2.11.1. Overview
- 15.2.11.2. Product Portfolio
- 15.2.11.3. Sales Footprint
- 15.2.11.4. Key Financials
- 15.2.11.5. SWOT Analysis
- 15.2.11.6. Strategy Overview
- 15.2.11.6.1. Marketing Strategy
- 15.2.11.6.2. Product Strategy
- 15.2.11.6.3. Channel Strategy
- 15.2.12. Pace Pharmacy
- 15.2.12.1. Overview
- 15.2.12.2. Product Portfolio
- 15.2.12.3. Sales Footprint
- 15.2.12.4. Key Financials
- 15.2.12.5. SWOT Analysis
- 15.2.12.6. Strategy Overview
- 15.2.12.6.1. Marketing Strategy
- 15.2.12.6.2. Product Strategy
- 15.2.12.6.3. Channel Strategy
- 15.2.13. Victoria Compounding Pharmacy
- 15.2.13.1. Overview
- 15.2.13.2. Product Portfolio
- 15.2.13.3. Sales Footprint
- 15.2.13.4. Key Financials
- 15.2.13.5. SWOT Analysis
- 15.2.13.6. Strategy Overview
- 15.2.13.6.1. Marketing Strategy
- 15.2.13.6.2. Product Strategy
- 15.2.13.6.3. Channel Strategy
- 15.2.14. Pratt's Compounding Pharmacy
- 15.2.14.1. Overview
- 15.2.14.2. Product Portfolio
- 15.2.14.3. Sales Footprint
- 15.2.14.4. Key Financials
- 15.2.14.5. SWOT Analysis
- 15.2.14.6. Strategy Overview
- 15.2.14.6.1. Marketing Strategy
- 15.2.14.6.2. Product Strategy
- 15.2.14.6.3. Channel Strategy
- 15.2.15. People's Choice Pharmacy
- 15.2.15.1. Overview
- 15.2.15.2. Product Portfolio
- 15.2.15.3. Sales Footprint
- 15.2.15.4. Key Financials
- 15.2.15.5. SWOT Analysis
- 15.2.15.6. Strategy Overview
- 15.2.15.6.1. Marketing Strategy
- 15.2.15.6.2. Product Strategy
- 15.2.15.6.3. Channel Strategy
- 15.2.1. Hoye's Pharmacy
16. Assumptions and Acronyms Used
17. Research Methodology
List of Tables
- Table 01: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Product
- Table 02: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Animal Type
- Table 03: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Formulations
- Table 05: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2014-2023 and Forecast 2023-2033, by Country
- Table 06: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Product
- Table 07: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Animal Type
- Table 08: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Formulations
- Table 09: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Product
- Table 10: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Anima Type
- Table 11: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis and Forecast 2014-2033, by Formulations
List of Figures
- Figure 01: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis, 2014-2022
- Figure 02: North America Vet Compounding Pharmacies Market Forecast & Y-o-Y Growth, 2023-2033
- Figure 03: North America Vet Compounding Pharmacies Market Absolute $ Opportunity (US$ Mn) Analysis, 2023-2033
- Figure 04: North America Vet Compounding Pharmacies Market Value Share (%) Analysis 2023 and 2033, by Product
- Figure 05: North America Vet Compounding Pharmacies Market Y-o-Y Growth (%) Analysis 2023-2033, by Product
- Figure 06: North America Vet Compounding Pharmacies Market Attractiveness Analysis 2023-2033, by Product
- Figure 07: North America Vet Compounding Pharmacies Market Value Share (%) Analysis 2023 and 2033, by Animal Type
- Figure 08: North America Vet Compounding Pharmacies Market Y-o-Y Growth (%) Analysis 2023-2033, by Animal Type
- Figure 09: North America Vet Compounding Pharmacies Market Attractiveness Analysis 2023-2033, by Animal Type
- Figure 10: North America Vet Compounding Pharmacies Market Value Share (%) Analysis 2023 and 2033, by Formulations
- Figure 11: North America Vet Compounding Pharmacies Market Y-o-Y Growth (%) Analysis 2023-2033, by Formulations
- Figure 12: North America Vet Compounding Pharmacies Market Attractiveness Analysis 2023-2033, by Formulations
- Figure 13: North America Vet Compounding Pharmacies Market Value Share (%) Analysis 2023 and 2033, by Country
- Figure 14: North America Vet Compounding Pharmacies Market Y-o-Y Growth (%) Analysis 2023-2033, by Country
- Figure 15: North America Vet Compounding Pharmacies Market Attractiveness Analysis 2023-2033, by Country
- Figure 16: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis, 2014-2022
- Figure 17: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Forecast, 2023-2033
- Figure 18: U.S. Vet Compounding Pharmacies Market Value Share, By Product (2023 E)
- Figure 19: U.S. Vet Compounding Pharmacies Market Value Share, By Animal Type (2023 E)
- Figure 20: U.S. Vet Compounding Pharmacies Market Value Share, By Formulations (2023 E)
- Figure 21: U.S. Vet Compounding Pharmacies Market Attractiveness Analysis By Product, 2023-2033
- Figure 22: U.S. Vet Compounding Pharmacies Market Attractiveness Analysis By Animal Type, 2023-2033
- Figure 23: U.S. Vet Compounding Pharmacies Market Attractiveness Analysis By Formulations, 2023-2033
- Figure 24: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis, 2014-2022
- Figure 25: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Forecast, 2023-2033
- Figure 26: Canada Vet Compounding Pharmacies Market Value Share, By Product (2023 E)
- Figure 27: Canada Vet Compounding Pharmacies Market Value Share, By Animal Type (2023 E)
- Figure 28: Canada Vet Compounding Pharmacies Market Value Share, By Formulations (2023 E)
- Figure 29: Canada Vet Compounding Pharmacies Market Attractiveness Analysis By Product, 2023-2033
- Figure 30: Canada Vet Compounding Pharmacies Market Attractiveness Analysis By Animal Type, 2023-2033
- Figure 31: Canada Vet Compounding Pharmacies Market Attractiveness Analysis By Formulations, 2023-2033
